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Results: Two hundred eigthy five (42%) subjects in the placebo group and
221 (32%) in the acarbose group converted to diabetes. The mean baseline
level of WBC was 6.33 (SD 1.65) G/L and for ALT 31.70 (21.14) U/L. Only
subjects with increased WBC levels had an elevated risk for diabetes (HR
1.44; p<0.001), but not subjects with elevated ALT levels (HR 1.10; p=0.36).
In multivariate analysis with metabolic syndrome (NCEP III), treatment
group, FPG, 2 hPG, HbA1C, triglycerides and WBC were independent pre-
dictors of newly diagnosed type 2 diabetes.
Conclusion: WBC but not ALT is a simple and routinely measured labora-
tory parameter which may be also used for risk estimation of developing
diabetes. However, ALT could not be confirmed as independent risk factor
in subjects with IGT.
Support: Research grant by Bayer AG
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Effects of lifestyle modification on metabolic parameters and carotid
intima-media thickness in patients with type 2 diabetes
S. Kim1, E. Kang1, S. Kang1, H. Lee1, K. Hur1, S. Lee2, J. Yoo3, B. Cha1,2,
H. Lee1,2;
1Internal Medicine, Yonsei University College of Medicine, Seoul, 2Brain
Korea 21 for Medical Science, Yonsei University, Seoul, 3Yonsei University
College of Nursing, Seoul, Republic of Korea.
Background and Aims: Lifestyle modification is known to have positive
effects on glycemic control and cardiovascular risk factors. Diabetes is a
risk factor for cardiovascular disease. The carotid intima-media thickness
(IMT) is considered to be an index of the progression of atherosclerosis.
The aim of this study was to evaluate the effect of a 6 month lifestyle modi-
fication intervention on metabolic parameters and carotid IMT in patients
with type 2 diabetes.
Materials and Methods: Sixty five patients with type 2 diabetes were ran-
domly assigned into 2 groups, the lifestyle modification (LSM) group and
the control (CON) group. The patients in the LSM group attended an inten-
sive lifestyle modification intervention program for 16 weeks and had
monthly meetings after the program. Patients in the CON group had no
change in their usual treatment. Fasting plasma glucose, 2 hour postpran-
dial glucose, HbA1c, lipid profiles, hsCRP, fasting insulin level, carotid IMT,
blood pressure, and body indices were measured at baseline and after 6
months.
Results: LSM group showed a significant reduction in HbA1c (-0.98 ± 1.22
vs. +0.05 ± 1.24%, p=0.002), fasting plasma glucose (-28.72 ± 26.44 vs.
+6.15 ± 44.91 mg/dl, p=0.022), and 2 hour postprandial glucose (–37.63 ±
44.79 vs. +14.77 ± 80.12 mg/dl, p=0.003) after 6 months. Total cholesterol,
triglyceride, HDL-cholesterol, LDL-cholesterol, HOMAIR, and hsCRP levels
showed no significant difference. Body weight (–2.01 ± 2.59 vs. +0.22 ± 1.73
kg, p=0.001), BMI (–0.80 ± 1.00 vs. +0.02 ± 0.80 kg/m2, p=0.003), systolic
blood pressure (–8.15 ± 15.92 vs. +0.42 ± 14.07 mmHg, p=0.041) were sig-
nificantly decreased in the LSM group. Significant carotid IMT regression
was seen in the LSM group after 6 months (mean IMT: –0.050 ± 0.144 vs.
+0.083 ± 0.167 mm, maximum IMT: –0.084 ± 0.197 vs. +0.07 ± 0.199 mm,
p=0.004, p=0.009, respectively).
Conclusion: Lifestyle modification in patients with type 2 diabetes had
positive effects on glycemic control, weight loss, and prevention of carotid
atherosclerosis progression.
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The role of renin-angiotensin system blockers in the prevention 
of new -onset diabetes: meta-analysis of randomized controlled trials
A. Alkhenizan, M. Elswes;
KFSHRC, Riyadh, Saudi Arabia.
Background and Aims: Diabetes is associated with significant morbidity
and mortality, especially when it is associated with cardiovascular disease.
Prevention of diabetes will have significant impact especially among high
risk patients.
Materials and Methods: We searched The Cochrane Controlled Trials Reg-
ister (CCTR), MEDLINE, and EMBASE in January 2005. We included Ran-
domized Controlled Trials (RCTs), in which outcomes of New -Onset Dia-
betes was reported. No language restrictions were applied. All identified
trials were reviewed independently by two reviewers to determine whether
trials should be included or excluded.
Results: Ten studies met inclusion criteria, including 77,541 participants.
There was a statistically significant reduction in the incidence of New -
Onset Diabetes in patients receiving Renin-Angiotensin System Blockers
(ACEI or ARB) compared to other antihypertensive agents (RR 0.79; 95%
CI 0.75–0.84, ARR=-0.02, NNT=50). There was a statistically significant
reduction in the incidence of New-Onset Diabetes in patients receiving
Renin-Angiotensin System Blockers compared to Diuretics, Conventional
antihypertensive therapy (Diuretics or B-Blockers), and Calcium Channel
Blockers (NNT=90,153, 62, respectively). There was a statistically signifi-
cant reduction in the incidence of New-Onset Diabetes in patients receiving
ACEI compared to Diuretics, and Conventional antihypertensive therapy.
There was a statistically significant reduction in the incidence of New-
Onset Diabetes in patients receiving ARB compared to other antihyperten-
sive agents.
Conclusion: Renin-Angiotensin System Blockers significantly prevent the
development of New-Onset Diabetes and should be utilized especially
among high risk patients like patients with metabolic syndrome.
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Effects of a community-based intervention programme promoting 
physical activity on risk factors for diabetes and cardiovascular disease
A. Jenum1, S. A. Andersen2, R. Bahr2, S. Graff-Iversen3, I. Holme2,
C. Lorentzen2, T. Raastad2, Y. Ommundsen2, A.-K. Oedegaard4,
K. I. Birkeland1;
1Aker/Ullevaal Diabetes Resarch Center, Oslo, 2Norwegian School of Sport
Sciences, Oslo, 3National Institute of Public Health, Oslo, 4City of Oslo,
Grorud District, Norway.
Background and Aims: Physical inactivity is an important risk factor for
type 2 diabetes. Lifestyle intervention programmes focusing on diet and
physical activity have documented that type 2 diabetes can be prevented in
high-risk groups, but this approach is insufficient to stem the world wide
epidemic of obesity and diabetes. Community-based strategies addressing
the population at large are highly requested. We therefore designed an
intervention study promoting physical activity on a district level in Oslo.
Materials and Methods: We selected the population in a low-income, urban
district with high mortality rates and high prevalence of diabetes, obesity
and physical inactivity for the intervention and the population in a neigh-
bour district for controls. Baseline investigation of 2950 participants, 30–67
years old, follow-up investigation of 1776 (67% of those eligible). Of these
56% were women, 18% non-western immigrants. A set of theory-driven,
low-cost intervention activities aimed at promoting physical activity was
implemented in the intervention district from 2000 to 2003, tailored
towards groups with different psychosocial readiness for change in physi-
cal activity. We used communication activities, invited to training sessions,
labelled walking trails and offered a low-threshold fitness-test twice yearly.
Main outcome measures were net changes observed between district
cohorts in self-reported physical activity, psycho-social mediators related
to physical activity, daily smoking, body weight, systolic blood pressure and
serum levels of glucose and lipids.
Results: The net increase in physical activity as measured by two self-
reported instruments was 9.5% (p=0.008) and 8.1% (p=0.02), and psy-
chosocial mediators for change improved more (MANOVA, combined vec-
tor; P=0.002) in the intervention compared to the control district. The net
proportion quitting smoking was 2.9% (95% confidence interval 0.1% to
4.0%, P= 0.043). The weight gain was less in the intervention district, with a
mean net difference of 1.2 kg (0.6 to 1.9, P=<0.001) in men and 0.3 kg (–0.4
to 0.9) in women. Beneficial effects were also seen for the levels of triglyc-
erides 0.16 mmol/l (0.06 to 0.25, P=0.002), cholesterol/HDL-cholesterol
ratio 0.12 (0.03 to 0.20, P=0.007) and systolic blood pressure 3.6 mm (2.2 to
4.8, P<0.001), and in men also for the serum level of glucose 0.35
(0.03–0.67) mmol/l.
Conclusion: A community-based, low-cost intervention programme
resulted in significant increase in physical activity in the intervention dis-
trict followed by beneficial changes in several risk factors for diabetes and
cardiovascular disease.
Support: The Norwegian Research Council
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Prenatal stress: effects on energy homeostasis and cognitive performance
A. C. M. Heinsbroek, G. van Dijk;
Animal Physiology, Unit Neuroendocrinology, University of Groningen,
Haren, The Netherlands.
Background and Aims: The metabolic syndrome is a growing health prob-
lem in western industrialized societies. Whereas environmental factors,
such as stress and diet, can propagate the aetiology of the metabolic syn-
drome during adulthood, one hypothesis states that they can also do so
during the perinatal stage. For instance, exposure to stress during gestation
is known to result in physiological, behavioral, and perhaps cognitive dete-
riorations during adulthood that finally lead to obesity and glucose intoler-
A 252
ance in aged rats. The changes in these parameters during young adulthood
are largely unknown. Therefore, we investigated the influence of prenatal
stress on energy balance, glucose homeostasis and cognitive performance
in rats between 5 and 7 months of age.
Materials and Methods: Pregnant Wistar rats were subjected to immuno-
logical stress (LPS injections), psychological stress (chronic mild stress,
CMS), or no stress at all. Body weight of the male offspring was measured
regularly, and at age of 5 months, these rats were surgically equipped with
jugular vein cannulas for blood sampling. To assess leptin sensitivity, the
effect of a bolus leptin injection (25 ug iv) on food intake was measured.
Intravenous glucose tolerance tests (IVGTT) and insulin sensitivity tests
(IST) were performed to examine glucose homeostasis. After this, cognitive
performance was tested in a novel object recognition test and an active
shock avoidance test.
Results: CMS resulted in heavier male offspring, whereas LPS had no effect
on offspring body weight. Neither CMS nor LPS caused major disturbing
effects on glucose homeostasis. In fact, the CMS animals appeared to be
more glucose tolerant during an intravenous glucose infusion. As opposed
to the seemingly similar regulation of substrate homeostasis, CMS as well
as LPS offspring performed less well in the “Novel Object Recognition” test
(i.e., a standard cognitive performance task) relative to controls.
Conclusion: We conclude that perinatal stress differentially affects cogni-
tive performance and regulation of energy balance in young adult off-
spring. Provided that perinatal stress leads to metabolic disregulation dur-
ing ageing, the results in the present study demonstrate that metabolic
disregulations are not required for the effects of prenatal stress on cogni-
tive performance.
This study was supported by a career development grant from the dutch
Diabetes Fonds to Dr. G. van Dijk on aetiology of the insulin resistance syn-
drome.
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Improved metabolic outcome and delayed structural rebuilding 
of pancreatic islets after regular intake of milk derivate in incipient 
diabetic Zucker rats (fa/fa)
S. Berg1, E.-J. Freyse1, K.-D. Kohnert1, P. Augstein1, J. Krauskopf 2,
E. Salzsieder1;
1Institut of Diabetes, Karlsburg, 2S.K.Enterprise GmbH, Hamburg,
Germany.
Background and Aims: Healthy nutrition is of key importance in prevent-
ing or even treating type 2 diabetes mellitus (T2DM). In this respect, the
beneficial effects of probiotics have increasingly attracted public attention.
The influence of a regular daily intake of a milk derivate (SMP) on the
metabolic outcome and the progress of T2DM in Zucker rats (ZR, fa/fa) was
studied.
Materials and Methods: Glucose-intolerante male fa/fa Zucker rats 15
weeks old were given daily either SMP in tap water ad libitum (25 g/l, SMP-
group) or tap water alone(CO-group). Body weight, water and food intake
and morning non-fasting blood glucose (BG) was determined weekly.
Before, 3 and 6 weeks after treatment insulin, triglycerides and OGTT were
monitored and 24 h blood glucose profiles were determined. At the end of
the study pancreata were examined by immunohistochemistry and mor-
phometry.
Results: SMP declined BG increase (5 weeks treatment: 6,1 ± 1,2 mmol/l vs.
7,5 ± 1,1 mmol/l in CO; p<0,05) and improved glucose tolerance (area
under the curve, G-AUC after 6 weeks: 569 ± 145 vs. 780 ± 138 mmol x min/l;
p<0,05). The insulin-AUC was increased with SMP (I-AUC: SMP=897 ± 120
vs. CO=745 ± 506 ng x min/l). The G-AUC correlated in SMP treated ani-
mals negatively with the portion of insulin producing cells in pancreatic
islets (r= –0,666, p< 0,05), which was increased in SMP vs. CO (61,1 ± 4,7 vs.
51,9 ± 3,9%).
Conclusion: Daily intake of SMP in Zucker rats reduced insulin resistance,
improved glucose tolerance and prevented structural rebuilding of pancre-
atic islets. This opens new avenues in the prophylaxis and / or treatment of
metabolic syndrome and type 2 diabetes. The experimental results should
be verified in clinical studies.
PS 56 
Regulation of weight and obesity
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Mutation analysis of small heterodimer partner (SHP, NROB2) gene
among 596 Chinese subjects and identification of four novel variants
S. Wu, Z. Yang, T. Zheng, H. Lu, K. Xiang;
Department of Endocrinology & Metabolism Shanghai No.6 People Hospi-
tal Shanghai Jiaotong University, Shanghai Diabetes Institute, Shanghai,
China.
Background and Aims: The atypical orphan nuclear receptor small
heterodimer partner (SHP, NROB2) modulates the transcription activity of
MODY1 gene HNF-4α. Mutations in SHP were associated with moderate
obesity among Japanese. The purpose of the study was to evaluate the
prevalence of SHP variants among obese Chinese men.
Materials and Methods: We screened the whole coding region and
intron/exon boundaries for SHP in 324 unrelated Chinese obese subjects
(BMI 27.8 ± 2.7, BMI ≥25 kg/m2 is the cut off for obesity in this study) and
272 unrelated nondiabetic and nonobese control subjects (BMI 20.3 ± 2.5,
BMI <23 kg/m2) by direct sequencing of the amplified polymerase chain
reaction products.
Results: We identified six variants in 324 Chinese obese subjects, which
included the previously reported mutations (H53fsdel10, R34X) in Japan-
ese obese subjects. The H53fsdel10 was identified in seven separate obese
carriers(2.2%) and R34X was identified in one carriers in this study. Addi-
tionally, a total of four novel mutations, including two missense mutations
(G174A and G192E), one silent mutation (P10P) and one variants in intron1
(IVS1+10 C→T) were identified. The G174A and G192E variants were each
identified in two separate obese carriers and P10P was identified in one
carrier, the IVS1+10 C→T variants was also identified in one carrier. The
overall frequency of the SHP mutations in Chinese obese objects in this
study was 3.7% (12/324). All the mutations present in the heterozygous
state. No mutations were identified in 272 nondiabetic lean controls
(P=0.00068). Although, it was previously well documented that H53fsdel10
and R34X mutation were associated with obesity among Japanese, whether
the four novel mutations have any functional significance needs further
investigation.
Conclusion: Genetic variation in the SHP gene may be a key genetic factor
responsible for moderate obesity among Chinese.
Support: Natural science foundation of China (30470813)
696
Genetic interaction between the IGF2 ApaI polymorphism and the insulin
variable number of tandem repeats in their associations with body mass
index in children
C. J. Petry1, K. K. Ong1, D. L. Wingate1, S. Ring2, M. E. Pembrey2,
D. B. Dunger1 and the ALSPAC Study Team;
1Paediatrics, University of Cambridge, 2Avon Longitudinal Study 
of Pregnancy And Childhood, University of Bristol, United Kingdom.
Background and Aims: The insulin (INS) gene variable number of tandem
repeats (VNTR) and single nucleotide polymorphisms (SNPs) in the
nearby IGF2 gene on chromosome 11 have been reported to be associated
with weight gain. We therefore sought association between these genetic
variants and weight at age 7 years in a normal population of children and
explored possible gene-gene interactions.
Materials and Methods: Genomic DNA was extracted from blood and
mouthwash samples from 1,400 children in the prospective Avon Longitu-
dinal Study of Pregnancy and Childhood (ALSPAC) birth cohort (the Chil-
dren in Focus and control sub-cohorts). Of these 621 also had microsatel-
lite-validated DNA samples from both their parents for transmission
disequilibrium testing. Plasma IGF-2 concentrations were measured at age
5 years and heights and weights were measured at age 7 years. Body mass
index (BMI) was calculated as weight (kg) divided by height (m)2, and was
converted into a standard deviation score (SDS) by reference to the full
ALSPAC cohort (n~14,000). All samples were genotyped for IGF2 ApaI
(rs680; G+820A) and XcmI (rs3842759; A+6815T) (two IGF2 SNPs reported
to be associated with BMI in adults), and HphI (rs689) as a surrogate for
INS VNTR class. Genotyping was performed by PCR followed by restriction
fragment length polymorphism analyses.
Results: The IGF2 XcmI SNP was associated with variation in plasma IGF-2
concentrations at age 5 years (geometric means: A/A 382 ng/ml, A/T 404,
T/T 446; p=0.001) but not with markers of childhood obesity. In contrast
both IGF2 ApaI (p<0.05) and INS VNTR (p<0.05) were independently
A 253
